Larimar Therapeutics, Inc. (LRMR)

Exchange NASDAQ
2.11


Currency in USD (Disclaimer)
Volume:
Day's Range:

LRMR Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-05-10 THOMAS FRANK E director 8,300.0 A-Award A 8,300.0 2.92 24,236.00
2022-05-10 LEFF JONATHAN S director 8,300.0 A-Award A 8,300.0 2.92 24,236.00
2022-05-10 Hamilton Thomas Edward director 8,300.0 A-Award A 8,300.0 2.92 24,236.00
2022-05-10 Barrett Peter director 8,300.0 A-Award A 8,300.0 2.92 24,236.00
2022-05-10 Truitt Joseph director 8,300.0 A-Award A 8,300.0 2.92 24,236.00
2022-05-10 Celano Michael officer: Chief Financial Officer 20,000.0 A-Award A 20,000.0 2.92 58,400.00
2022-05-10 BEN-MAIMON CAROLE director, officer: President and CEO 40,000.0 A-Award A 40,000.0 2.92 116,800.00
2022-05-10 Flynn James E other: * Director by Deputization 8,300.0 A-Award A 8,300.0 2.92 24,236.00
2022-01-18 Celano Michael officer: Chief Financial Officer 80,000.0 A-Award A 80,000.0 8.75 700,000.00
2022-01-18 BEN-MAIMON CAROLE director, officer: President and CEO 182,000.0 A-Award A 182,000.0 8.75 1,592,500.00
2021-06-30 Hamilton Thomas Edward director 190,130.0 P-Purchase A 56,710.0 8.75 496,212.50
2021-06-30 Flynn James E director, 10 percent owner, other: * Director by Deputization 1,943,423.0 P-Purchase A 228,571.0 8.75 1,999,996.25
2021-06-30 Flynn James E director, 10 percent owner, other: * Director by Deputization 1,943,406.0 P-Purchase A 228,569.0 8.75 1,999,978.75
2021-06-30 Flynn James E director, 10 percent owner, other: * Director by Deputization 1,943,420.0 P-Purchase A 228,570.0 8.75 1,999,987.50
2021-05-12 THOMAS FRANK E director 8,300.0 A-Award A 8,300.0 0.00 0.00
2021-05-12 Hamilton Thomas Edward director 8,300.0 A-Award A 8,300.0 0.00 0.00
2021-05-12 Flynn James E director, 10 percent owner, other: * Director by Deputization 8,300.0 A-Award A 8,300.0 10.34 85,822.00
2021-05-12 Truitt Joseph director 8,300.0 A-Award A 8,300.0 0.00 0.00
2021-05-12 LEFF JONATHAN S director 8,300.0 A-Award A 8,300.0 0.00 0.00
2021-05-12 Daniel Thomas O director 8,300.0 A-Award A 8,300.0 10.34 85,822.00
2021-05-12 Barrett Peter director 8,300.0 A-Award A 8,300.0 0.00 0.00
2021-01-19 Celano Michael officer: Chief Financial Officer 42,000.0 A-Award A 42,000.0 0.00 0.00
2021-01-19 BEN-MAIMON CAROLE director, officer: President and CEO 106,700.0 A-Award A 106,700.0 19.61 2,092,387.00
2020-09-29 BEN-MAIMON CAROLE director, officer: President and CEO 411,400.0 A-Award A 411,400.0 11.90 4,895,660.00
2020-09-29 Flynn James E director, 10 percent owner, other: * Director by Deputization 16,600.0 A-Award A 16,600.0 0.00 0.00
2020-09-29 Hamilton Thomas Edward director 16,600.0 A-Award A 16,600.0 0.00 0.00
2020-09-29 THOMAS FRANK E director 16,600.0 A-Award A 16,600.0 11.90 197,540.00
2020-09-29 Truitt Joseph director 16,600.0 A-Award A 16,600.0 0.00 0.00
2020-09-29 Barrett Peter director 16,600.0 A-Award A 16,600.0 0.00 0.00
2020-09-29 Daniel Thomas O director 16,600.0 A-Award A 16,600.0 0.00 0.00
2020-09-29 LEFF JONATHAN S director 16,600.0 A-Award A 16,600.0 0.00 0.00
2020-09-29 Celano Michael officer: Chief Financial Officer 84,100.0 A-Award A 84,100.0 0.00 0.00
2020-06-26 CHONDRIAL THERAPEUTICS HOLDINGS, LLC 10 percent owner 8.0 J-Other D 6,091,242.0 0.00 0.00
2020-06-26 BEN-MAIMON CAROLE director, officer: President and CEO 25,083.0 J-Other A 25,083.0 0.00 0.00
2020-06-26 Hamilton Thomas Edward director 292,853.0 J-Other A 159,433.0 0.00 0.00
2020-06-26 Hamilton Thomas Edward director 133,420.0 J-Other A 133,420.0 0.00 0.00
2020-05-28 Celano Michael officer: Chief Financial Officer 60,479.0 A-Award A 60,479.0 11.88 718,490.52
2019-06-26 LAMATTINA JOHN L director 27,000.0 A-Award A 27,000.0 0.00 0.00
2019-06-26 THOMAS FRANK E director 27,000.0 A-Award A 27,000.0 0.00 0.00
2019-06-26 McDonough Cameron Geoffrey director 27,000.0 A-Award A 27,000.0 0.00 0.00
2019-06-26 PEREZ ROBERT J director 27,000.0 A-Award A 27,000.0 0.00 0.00
2019-06-26 EVERETT WENDY director 27,000.0 A-Award A 27,000.0 0.00 0.00
2019-06-26 Daniel Thomas O director 27,000.0 A-Award A 27,000.0 0.00 0.00
2019-06-26 Barrett Peter director 27,000.0 A-Award A 27,000.0 0.00 0.00
2019-04-02 Singhal Priya officer: Head of Research & Development 375,000.0 A-Award A 375,000.0 0.00 0.00
2019-01-24 McDonough Cameron Geoffrey director 11,804.0 A-Award A 11,804.0 0.00 0.00
2019-01-24 PEREZ ROBERT J director 5,322.0 A-Award A 4,423.0 0.00 0.00
2019-01-24 PEREZ ROBERT J director 5,717.0 A-Award A 5,717.0 0.00 0.00
2019-01-24 LAMATTINA JOHN L director 31,376.0 A-Award A 10,844.0 0.00 0.00
2019-01-24 Daniel Thomas O director 13,280.0 A-Award A 13,280.0 0.00 0.00
2019-01-24 Barrett Peter director 21,396.0 A-Award A 21,396.0 0.00 0.00
2019-01-22 Hatfield Jeffrey S. director, officer: Chief Executive Officer 525,000.0 A-Award A 525,000.0 0.00 0.00
2019-01-22 McVeigh Brian officer: Chief Business Officer 125,000.0 A-Award A 125,000.0 0.00 0.00
2019-01-22 KIM DENNIS D officer: Chief Medical Officer 95,000.0 A-Award A 95,000.0 0.00 0.00
2019-01-22 Allen Patricia L officer: Chief Financial Officer 125,000.0 A-Award A 125,000.0 0.00 0.00
2018-06-29 Atlas Venture Fund VII L P 10 percent owner 11.0 J-Other D 234,321.0 0.00 0.00
2018-06-29 Atlas Venture Fund VII L P 10 percent owner 3,506,184.0 J-Other D 1,126,546.0 0.00 0.00
2018-06-28 Hughes Thomas E. director, officer: See Remarks 125,247.0 S-Sale D 32,000.0 10.00 320,000.00
2018-06-06 LAMATTINA JOHN L director 20,000.0 A-Award A 20,000.0 0.00 0.00
2018-06-06 EVERETT WENDY director 40,000.0 A-Award A 40,000.0 0.00 0.00
2018-06-06 EVERETT WENDY director 20,000.0 A-Award A 20,000.0 0.00 0.00
2018-06-06 Daniel Thomas O director 20,000.0 A-Award A 20,000.0 0.00 0.00
2018-06-06 THOMAS FRANK E director 20,000.0 A-Award A 20,000.0 0.00 0.00
2018-06-06 PEREZ ROBERT J director 20,000.0 A-Award A 20,000.0 0.00 0.00
2018-06-06 McDonough Cameron Geoffrey director 20,000.0 A-Award A 20,000.0 0.00 0.00
2018-06-06 Barrett Peter director 20,000.0 A-Award A 20,000.0 0.00 0.00
2018-05-29 McVeigh Brian officer: Chief Business Officer 225,000.0 A-Award A 225,000.0 0.00 0.00
2018-03-07 Hughes Thomas E. director, officer: See Remarks 157,247.0 S-Sale D 5,000.0 10.00 50,000.00
2018-02-22 KIM DENNIS D officer: Chief Medical Officer 125,000.0 A-Award A 125,000.0 0.00 0.00
2018-02-22 Hatfield Jeffrey S. director, officer: Chief Executive Officer 275,000.0 A-Award A 275,000.0 0.00 0.00
2018-02-22 Allen Patricia L officer: Chief Financial Officer 125,000.0 A-Award A 125,000.0 0.00 0.00
2018-02-22 Hughes Thomas E. director, officer: See Remarks 275,000.0 A-Award A 275,000.0 7.77 2,136,750.00
2018-01-03 PEREZ ROBERT J director 9,421.0 A-Award A 9,421.0 0.00 0.00
2018-01-03 Booth Bruce director, 10 percent owner 8,509.0 A-Award A 8,509.0 0.00 0.00
2018-01-03 Barrett Peter director 17,627.0 A-Award A 17,627.0 0.00 0.00
2018-01-03 Daniel Thomas O director 19,452.0 A-Award A 8,687.0 0.00 0.00
2018-01-03 McDonough Cameron Geoffrey director 9,725.0 A-Award A 9,725.0 5.18 50,375.50
2018-01-03 LAMATTINA JOHN L director 20,532.0 A-Award A 9,169.0 5.18 47,495.42
2017-12-29 Hatfield Jeffrey S. director, officer: Chief Executive Officer 1,100,000.0 A-Award A 1,100,000.0 3.40 3,740,000.00
2017-10-13 Heller Frances K director 47,961.0 P-Purchase A 10,000.0 0.00 0.00
2017-10-09 Hughes Thomas E. director, officer: See Remarks 275,000.0 A-Award A 275,000.0 0.00 0.00
2017-10-09 Hatfield Jeffrey S. director, officer: Chief Executive Officer 550,000.0 A-Award A 550,000.0 0.00 0.00
2017-07-11 KIM DENNIS D officer: Chief Medical Officer 21,443.0 P-Purchase A 10,000.0 0.00 0.00
2017-06-21 PEREZ ROBERT J director 14,500.0 A-Award A 14,500.0 3.95 57,275.00
2017-06-21 Daniel Thomas O director 14,500.0 A-Award A 14,500.0 0.00 0.00
2017-06-21 THOMAS FRANK E director 14,500.0 A-Award A 14,500.0 0.00 0.00
2017-06-21 Heller Frances K director 14,500.0 A-Award A 14,500.0 0.00 0.00
2017-06-21 McDonough Cameron Geoffrey director 14,500.0 A-Award A 14,500.0 0.00 0.00
2017-06-21 Barrett Peter director 14,500.0 A-Award A 14,500.0 0.00 0.00
2017-06-21 Booth Bruce director, 10 percent owner 14,500.0 A-Award A 14,500.0 0.00 0.00
2017-06-21 LAMATTINA JOHN L director 14,500.0 A-Award A 14,500.0 0.00 0.00
2017-05-11 Hughes Thomas E. director, officer: See Remarks 0.0 M-Exempt D 18,928.0 0.75 14,196.00
2017-05-11 Hughes Thomas E. director, officer: See Remarks 83,088.0 M-Exempt A 18,928.0 0.75 14,196.00
2017-05-11 Hughes Thomas E. director, officer: See Remarks 157,371.0 M-Exempt A 68,073.0 0.82 55,819.86
2017-05-11 Hughes Thomas E. director, officer: See Remarks 89,298.0 M-Exempt A 6,210.0 0.75 4,657.50
2017-05-11 KIM DENNIS D officer: Chief Medical Officer 11,443.0 P-Purchase A 9,800.0 4.40 43,120.00
2017-05-10 KIM DENNIS D officer: Chief Medical Officer 1,643.0 P-Purchase A 200.0 4.40 880.00
2017-02-13 Booth Bruce director, 10 percent owner 12,003.0 A-Award A 12,003.0 4.18 50,172.54
2017-02-13 Daniel Thomas O director 10,765.0 A-Award A 10,765.0 4.18 44,997.70
2017-02-13 LAMATTINA JOHN L director 11,363.0 A-Award A 11,363.0 4.18 47,497.34

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.